The global blood screening market was valued at USD 3.40 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. This growth is primarily driven by an increasing number of blood donations worldwide, which requires stringent screening protocols to prevent the transmission of infections through transfusions. Technological advancements,...

The global blood screening market, valued at USD 3.40 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. This anticipated growth is largely due to a global increase in blood donations, which heightens the need for rigorous screening processes to detect transfusion-transmissible infections and ensure patient safety. Advances in technology,...